Am J Surg

1. OU M, Dua A, Zhao B
   Outcomes after right hemicolectomy for ascending colon cancer: A comparison of academic versus community hospitals.
   Am J Surg. 2026;260:117143.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. MORGAN RB, Neilson T, Keeling S, Kearse L, et al
   Risk of Ovarian Metastasis in Colorectal Cancer-Related Carcinomatosis.
   Ann Surg Oncol. 2026 Jul 16. doi: 10.1245/s10434-026-20254.
   

   >> Share

   
   
3. YU AT, Pitcher C, Khaitov S, Tabrizian P, et al
   ASO Visual Abstract: Risk Factors for Anastomotic Leaks in Simultaneous Resection of Primary Colon Cancer with Synchronous Liver Metastasis: a NSQIP Study.
   Ann Surg Oncol. 2026 Jul 15. doi: 10.1245/s10434-026-20233.
   

   >> Share

   
   
4. MURTHY SS, Mongiu A, Trapani D, Sylla P, et al
   GLP-1 Receptor Agonists and Colorectal Cancer Outcomes: Hype, Hope, or Hidden Confounding?
   Ann Surg Oncol. 2026 Jul 15. doi: 10.1245/s10434-026-20206.
   

   >> Share

   
   

   
   BMC Cancer

5. TAO D, He H, Chen J, Li X, et al
   Preoperative tumor marker burden score predicts survival in colorectal cancer according to tumor size.
   BMC Cancer. 2026 Jul 16. doi: 10.1186/s12885-026-16563.
   

   >> Share

   
   
6. LIU Y, He JT, Lin GH, Fu C, et al
   Treatment outcomes of fruquintinib combined with PD-1 inhibitors in advanced colorectal cancer: a reconstructed patient-level meta-analysis of retrospective real-world studies.
   BMC Cancer. 2026 Jul 15. doi: 10.1186/s12885-026-16420.
   

   >> Share

   
   
7. YANG K, Li H, Dong X, Lin J, et al
   Combining tertiary lymphoid structures and tumor stroma percentage for predicting prognosis and chemotherapy benefits in stage II-III colorectal cancer.
   BMC Cancer. 2026 Jul 14. doi: 10.1186/s12885-026-16542.
   

   >> Share

   
   
8. YANG L, Han Y, Ji J, Wang Y, et al
   Uncovering the mechanism of DCLK3 in colorectal cancer progression through WGCNA and machine learning.
   BMC Cancer. 2026 Jul 10. doi: 10.1186/s12885-026-16479.
   

   >> Share

   
   
9. BANKEN E, Borg M, van Hellemond IEG, van Ravensteijn SG, et al
   A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: st
   BMC Cancer. 2026;26:838.
   

   >> Share

   
   

   
   BMC Gastroenterol

10. CHEN Q, Xu Q, Zhang L
    Prognostic value of lncRNA DARS-AS1 in colorectal cancer and its regulatory effect on tumor progression.
    BMC Gastroenterol. 2026 Jul 16. doi: 10.1186/s12876-026-05110.
    

    >> Share

    
    
11. HOSSEINI-HEMATABADI RA, Matboo M, Namazee M, Sadr Arhami A, et al
    Association between mercury levels and colorectal cancer: a systematic review, meta-analysis.
    BMC Gastroenterol. 2026 Jul 10. doi: 10.1186/s12876-026-05099.
    

    >> Share

    
    

    
    Br J Cancer

12. DORJKHORLOO G, Erkhem-Ochir B, Shiraishi T, Okami H, et al
    High KPNA2 expression predicts poor prognosis in pathological T4 colorectal cancer by importing c-Myc into the nucleus to suppress p53-dependent p21 expression.
    Br J Cancer. 2026 Jul 17. doi: 10.1038/s41416-026-03552.
    

    >> Share

    
    
13. NOHR AK, Overby MG, Nielsen MM, Torp EA, et al
    Combining genome-wide polygenic scores with registry data for colorectal cancer risk-based screening.
    Br J Cancer. 2026 Jul 15. doi: 10.1038/s41416-026-03532.
    

    >> Share

    
    

    
    Cancer

14. 
    Trial shows no DFS benefit from neoadjuvant chemotherapy versus upfront surgery in locally advanced colon cancer.
    Cancer. 2026;132:e70474.
    

    >> Share

    
    

    
    Cancer Res

15. HAO S, Sato Y, Liu Z, Lizardo D, et al
    Targeting WRN Helicase in Microsatellite Instable Colorectal Cancer Induces Antitumor Immunity through Extrachromosomal Circular DNA Release.
    Cancer Res. 2026 Jul 16. doi: 10.1158/0008-5472.CAN-25-3567.
    

    >> Share

    
    
16. MCANDREWS KM
    Oncogenic KRAS Promotes Extracellular DNA Clearance to Drive Immunosuppression in Colorectal Cancer.
    Cancer Res. 2026;86:3371-3373.
    

    >> Share

    
    
17. LIU A, Zuo F, Li M, Yin L, et al
    Soluble Uric Acid Drives CD8+ T-cell Exhaustion by Inducing KSR1-Mediated MAPK Hyperactivation.
    Cancer Res. 2026;86:3459-3479.
    

    >> Share

    
    

    
    Clin Cancer Res

18. ZHANG Q, Lin L, Wang W, He L, et al
    Non-Armored GCC-targeting CAR-T cell therapy demonstrates significant efficacy in patients with advanced colorectal cancer.
    Clin Cancer Res. 2026 Jul 17. doi: 10.1158/1078-0432.CCR-26-0854.
    

    >> Share

    
    

    
    Dis Colon Rectum

19. YANG H, Jiang P, Zhang Z, Zhou Y, et al
    Laparoscopic En Bloc Para-aortic Lymphadenectomy Up to the Renal Vein for Colorectal Cancer: How I Do It?
    Dis Colon Rectum. 2026;69:2120-2124.
    

    >> Share

    
    
20. HULSE JC, Quinn KM, Oberholtzer NP, Mattila CM, et al
    Single-Institution Experience Using Circulating Tumor DNA to Monitor Recurrence in Rectal Cancer.
    Dis Colon Rectum. 2026;69:2067-2073.
    

    >> Share

    
    
21. GAGNON-CHOY N, Robert L, Pang AJ, Ghitulescu GD, et al
    Glycated Hemoglobin as a Predictor of Postoperative Outcomes After Elective Colorectal Surgery.
    Dis Colon Rectum. 2026;69:2083-2092.
    

    >> Share

    
    
22. GEITENBEEK RTJ, Duhoky R, Burghgraef TA, Piozzi GN, et al
    Laparoscopic Versus Robot-Assisted Low Anterior Resection With Mesorectal Excision for Rectal Cancer (2014-2021): A Propensity Score-Weighted Multicenter Cohort Study of Long-term Oncological Outcomes (RESOLUTION).
    Dis Colon Rectum. 2026;69:2052-2066.
    

    >> Share

    
    
23. SU C, Lian Y, Wan X, Zhang S, et al
    Short-Course Radiotherapy Integrated With Immunochemotherapy Gives a Higher Pathological Complete Response Compared With the Long-Course Chemoradiotherapy With Chemotherapy in Total Neoadjuvant Therapy for Locally Advanced Rectal Carcinoma in the Real
    Dis Colon Rectum. 2026;69:2040-2051.
    

    >> Share

    
    
24. NEWLAND JJ, Grunhut J, Belcher R, Lopez KE, et al
    Trends in Colorectal Dysplasia in Patients with Inflammatory Bowel Disease.
    Dis Colon Rectum. 2026 May 25. doi: 10.1097/DCR.0000000000004289.
    

    >> Share

    
    
25. SHIOMI A, Akagi T, Kajikawa R, Katayama H, et al
    Three-Year Follow-Up of the Randomized Trial Comparing Open Versus Laparoscopic Surgery for Primary Tumor Resection in Patients With Non-Curable Stage IV Colon Cancer (JCOG1107).
    Dis Colon Rectum. 2026 Jul 16. doi: 10.1097/DCR.0000000000004373.
    

    >> Share

    
    

    
    Eur J Cancer

26. REMOND M, Aparicio T, Martinez-Tapia C, Le Malicot K, et al
    Predicting severe toxicities and mortality in older patients with colorectal cancer: An analysis of 3 clinical trials and 3 prospective cohorts.
    Eur J Cancer. 2026;245:116935.
    

    >> Share

    
    

    
    Eur J Surg Oncol

27. KITAGUCHI D, Forgione A, Serra-Aracil X, Innocenzi C, et al
    Systematic review and Bayesian network meta-analysis comparing multiple anastomotic techniques after total mesorectal excision in rectal cancer.
    Eur J Surg Oncol. 2026;52:111966.
    

    >> Share

    
    
28. VERDONSCHOT KHM, Vissers PAJ, van den Boezem PB, Overduin CG, et al
    Changes in liver resections and associated outcomes over thirty years: a nationwide analysis using a machine learning approach.
    Eur J Surg Oncol. 2026;52:111964.
    

    >> Share

    
    
29. LIN Z, Li X, Yi T, Hua H, et al
    Prognostic value and spatial transcriptomic landscape of histopathological growth patterns in synchronous colorectal liver metastases.
    Eur J Surg Oncol. 2026;52:111951.
    

    >> Share

    
    
30. MAERTEN P, Wolthuis A, D'Hoore A, Bislenghi G, et al
    Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative review.
    Eur J Surg Oncol. 2026;52:111910.
    

    >> Share

    
    
31. SCHRAEPEN C, Rasschaert G, Maerten P, Bislenghi G, et al
    Young onset rectal cancer (YORC): a descriptive tertiary center analysis.
    Eur J Surg Oncol. 2026;52:111925.
    

    >> Share

    
    

    
    Gastroenterology

32. HAO S, Sato Y, Battaglin F, Xiu J, et al
    A DR5/Ligase 3-mediated feedback loop perpetuates immunogenicity in mismatch repair deficient colorectal cancer.
    Gastroenterology. 2026 Jul 16:S0016-5085(26)07034.
    

    >> Share

    
    

    
    Gastrointest Endosc

33. TU W, Xu L
    Corrigendum to "Refining cost-effectiveness modeling of colorectal cancer screening in average-risk Asian populations: implications of risk-based stratification and free screening policies" Gastrointest Endosc 2026;103:1100.
    Gastrointest Endosc. 2026 Jul 15:S0016-5107(26)06817.
    

    >> Share

    
    
34. LEGGETT CL, Plowman RS, Surace L, Gorospe E, et al
    Computer-aided polyp detection multicenter international randomized controlled study with a focus on community clinics: Geriatric Assessment-Driven Intervention clinical trial.
    Gastrointest Endosc. 2026;104:277-285.
    

    >> Share

    
    
35. SFERRAZZA S, Calabrese G, Maida M, Andrisani G, et al
    Stenosis development after circumferential colorectal endoscopic submucosal dissection: a multicenter analysis of predictive factors and outcomes.
    Gastrointest Endosc. 2026;104:266-276.
    

    >> Share

    
    

    
    Int J Colorectal Dis

36. J MA, F LM, D MV, L PS, et al
    Automated deep learning model for predicting pathological complete response in rectal cancer: A tool to organ-preserving strategies.
    Int J Colorectal Dis. 2026;41:119.
    

    >> Share

    
    
37. AMMER E, Winter S, Ammer-Herrmenau C, Riebeling JM, et al
    Patient-reported outcomes in low anterior resection syndrome: a comparison of open and robotic surgery.
    Int J Colorectal Dis. 2026;41:122.
    

    >> Share

    
    

    
    Int J Oncol

38. ZHONG L, Sun M, Wu D, Zeng Y, et al
    YAP1?mediated cytoplasmic?nuclear translocation of SREBP2 promotes colorectal cancer via regulation of cholesterol metabolism.
    Int J Oncol. 2026;69:105.
    

    >> Share

    
    

    
    J Am Coll Surg

39. HILL AL, Cullinan DR, Ahmed O, Wesson R, et al
    Deceased Donor Liver Transplantation and Postoperative Survival in Patients with Unresectable Colorectal Liver Metastases: A Retrospective Multicenter Study.
    J Am Coll Surg. 2026 Mar 18. doi: 10.1097/XCS.0000000000001925.
    

    >> Share

    
    

    
    J Surg Oncol

40. WORKU EB, Woldesenbet SA, Chatzipanagiotou OP, Pawlik TM, et al
    Patterns of Colorectal Cancer Diagnosis in Older Adults: A SEER-Medicare Analysis of Health and Economic Impact of Missed Screening Opportunities.
    J Surg Oncol. 2026 Jul 16. doi: 10.1002/jso.70338.
    

    >> Share

    
    
41. ZHANG GQ, Brooks ES, Melnitchouk N, Irani JL, et al
    Treatment Variation Impacts Survival Among Patients With Early-Onset Metastatic Colorectal Cancer.
    J Surg Oncol. 2026 Jul 15. doi: 10.1002/jso.70340.
    

    >> Share

    
    
42. SUSS NR, Johnson R, Olortegui KS, Liauw SL, et al
    Pelvic MRI Following Total Neoadjuvant Therapy for Rectal Cancer Poorly Predicts a Complete Clinical Response.
    J Surg Oncol. 2026;133:1016-1022.
    

    >> Share

    
    

    
    Oncogene

43. LIU Y, Siegfried G, Pernot S, He Z, et al
    Furin sustains tumor-promoting signals in KRAS- and BRAF-mutated colorectal cancer by engaging the TGF-beta1-COX-2 axis in a reciprocal regulatory network.
    Oncogene. 2026 Jul 12. doi: 10.1038/s41388-026-03875.
    

    >> Share

    
    

    
    PLoS One

44. KASAGGA B, Ssempebwa P, Kikuba G, E Egbe F, et al
    Prevalence and factors associated with treatment delay among colorectal cancer patients at Mulago National Referral Hospital and the Uganda Cancer Institute: A cross-sectional study.
    PLoS One. 2026;21:e0353668.
    

    >> Share

    
    
45. FAIRMAN CM, Brooks AM, Candow DG, Jackson KE, et al
    Examining the feasibility and preliminary effects of resistance exercise training and creatine supplementation in individuals treated for colorectal cancer.
    PLoS One. 2026;21:e0353630.
    

    >> Share

    
    
46. TO HTT, Vu NTH, Tong HND, Nguyen DTA, et al
    Prevalence and risk factors for colorectal neoplasia in a self-selected Vietnamese screening cohort undergoing self-funded colonoscopy.
    PLoS One. 2026;21:e0352998.
    

    >> Share

    
    
47. SOLAK HC, Mert N, Leblebici A, Isik Z, et al
    Could molecular variations be predictive in right and left colon cancer in different gender and age groups?
    PLoS One. 2026;21:e0351228.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

48. ZHAO Y, Hu X, Li Y, Zhang J, et al
    Oncogenic snoRNA SNORD78 fuels colorectal cancer by protecting the m(6)A reader IMP2 to enhance phospholipid metabolism.
    Proc Natl Acad Sci U S A. 2026;123:e2531283123.
    

    >> Share

    
    

    
    World J Surg

49. JU J, Li Y, He Q, Wang Y, et al
    Postoperative Function and Quality of Life of Patients With Low Rectal Cancer: A Multidimensional Comparison Between Low Anterior Resection and Abdominoperineal Resection.
    World J Surg. 2026;50:1775-1785.
    

    >> Share

    
    
50. SAROFIM M, Morris DL
    Distinct Patterns of Colorectal Peritoneal Metastases at Initial and Repeat Cytoreductive Surgery.
    World J Surg. 2026;50:2005-2007.
    

    >> Share

    
    
51. COS H, Valenzuela CD, Moaven O, Leonard G, et al
    Readmissions After Surgery for Colorectal Liver Metastases: A Propensity Score Analysis From the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).
    World J Surg. 2026;50:1974-1981.
    

    >> Share

    
    
52. KITAGAWA Y, Miki H, Yamamoto T, Watanabe J, et al
    Insurance Co-Payment Status and Advanced-Stage Presentation of Colorectal Cancer in a Universal Healthcare System: A Surgical Cohort Study From Japan.
    World J Surg. 2026 Jul 12. doi: 10.1002/wjs.70500.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share